Director, HTA Biostatistics — Strategic Evidence Leader (Dublin)

IE02 (FCRS = IE002) Novartis Ireland Ltd; Dublin; Hybrid; EUR 104,000 - 193,000; Full time

Benefits offered by this job

Hybrid working

Annual bonus eligibility

Flexible parental leave

Health insurance

Job summary

Novartis Ireland Ltd. in Dublin seeks an Associate Director/Director of Biostatistics to lead HTA, pricing and reimbursement and market access initiatives.

You will provide strategic statistical leadership across the product lifecycle to support payer decisions, and collaborate with international teams to deliver robust evidence. The role requires a PhD or equivalent with extensive HTA experience and strong communication skills to influence senior stakeholders in a global matrix.

Qualifications

• PhD or equivalent with extensive HTA/reimbursement evidence experience.
• Ability to lead complex, cross-regional HTA projects in a global matrix.
• Excellent interpersonal and communication skills for diverse stakeholders.

Responsibilities

• Provide strategic statistical leadership for HTA, pricing, reimbursement, and market access activities.
• Lead and coordinate HTA submissions, evidence synthesis, and communication with payers and regulators.
• Mentor biostatisticians and contribute to standards, templates, and automation in HTA analyses.

Skills

HTA experience

Statistical leadership

Cross-functional collaboration

Publications and communications

Education

PhD in Statistics/Biostatistics/Mathematics or related field

Master’s degree with 12+ years relevant experience

Job description

Novartis Ireland Ltd. in Dublin seeks an Associate Director/Director of Biostatistics to lead HTA, pricing and reimbursement and market access initiatives.

You will provide strategic statistical leadership across the product lifecycle to support payer decisions, and collaborate with international teams to deliver robust evidence. The role requires a PhD or equivalent with extensive HTA experience and strong communication skills to influence senior stakeholders in a global matrix.